Aantal gebruikers 2020-2024 voor ATC-subgroep C10AX : Overige antilipaemica
- Raming voor de totale Zvw-populatie
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| C10AX06 Omega-3-vetzuurpreparaat (Vazkepa ®) | . | . | . | 74 | 550 |
| C10AX09 Ezetimib (Ezetrol ®) | 175.130 | 193.950 | 215.550 | 242.700 | 267.220 |
| C10AX12 Lomitapide (Lojuxta ®) | 9 | 9 | 9 | 7 | 7 |
| C10AX13 Evolocumab (Repatha ®) | 11.572 | 13.299 | 15.602 | 17.869 | 21.420 |
| C10AX14 Alirocumab (Praluent ®) | 8.877 | 10.723 | 12.700 | 14.964 | 18.370 |
| C10AX15 Bempedoinezuur (Nilemdo ®) | . | . | . | 925 | 2.331 |
| C10AX16 Inclisiran (Leqvio ®) | . | . | 794 | 1.574 | 2.509 |
| C10AX18 Volanesorsen (Waylivra ®) | . | . | . | . | 1 |